Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 16alpha-gitoxin
1. Anhydrogitalin
2. Pseudodigitoxin
3. Bigitalin
4. 4562-36-1
5. Gitoxigenin 3-o-tridigitoxoside
6. Gitoksin
7. Gitoxim
8. Vor2td6so4
9. Chebi:28503
10. 3beta-[2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyloxy]-14,16beta-dihydroxy-5beta-card-20(22)-enolide
11. Gitoxigenin-tridigitoxosid [german]
12. Gitoxigenin-tridigitoxosid
13. Einecs 224-934-5
14. Unii-vor2td6so4
15. Nsc 95099
16. Brn 0077015
17. Nsc-95099
18. Gitoxin [mi]
19. Gitoxin [who-dd]
20. Schembl309847
21. Chembl109317
22. Gitoxin, >=99% (hplc)
23. Dtxsid101017007
24. Lmst01120017
25. Zinc238809171
26. 3-[(3s,5r,8r,9s,10s,13r,14s,16s,17r)-3-[(2r,4s,5s,6r)-5-[(2s,4s,5s,6r)-5-[(2s,4s,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-14,16-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2h-furan-5-one
27. Card-20(22)-enolide, 3-((o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-o-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl)oxy)-14,16-dihydroxy-, (3beta,5beta,16beta)-
28. Hy-136933
29. Cs-0135363
30. C08866
31. W-202805
32. Q27103741
33. Gitoxin, European Pharmacopoeia (ep) Reference Standard
34. Gitoxin, United States Pharmacopeia (usp) Reference Standard
35. (3.beta.,5.beta.,16.beta.)-3-((o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-o-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl)oxy)-14,16-dihydroxycard-20(22)-enolide
36. 3.beta.-((2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-.beta.-d-ribo-hexopyranosyl)oxy)-14,16.beta.-dihydroxy-5.beta.-card-20(22)-enolide
37. 3beta-[2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-d-ribo-hexopyranosyloxy]-14,16beta-dihydroxy-5beta-card-20(22)-enolide
| Molecular Weight | 780.9 g/mol |
|---|---|
| Molecular Formula | C41H64O14 |
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 6 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 7 |
| Exact Mass | 780.42960671 g/mol |
| Monoisotopic Mass | 780.42960671 g/mol |
| Topological Polar Surface Area | 203 Ų |
| Heavy Atom Count | 55 |
| Formal Charge | 0 |
| Complexity | 1450 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 21 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Gitoxin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gitoxin, including repackagers and relabelers. The FDA regulates Gitoxin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gitoxin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gitoxin supplier is an individual or a company that provides Gitoxin active pharmaceutical ingredient (API) or Gitoxin finished formulations upon request. The Gitoxin suppliers may include Gitoxin API manufacturers, exporters, distributors and traders.
Gitoxin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gitoxin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gitoxin GMP manufacturer or Gitoxin GMP API supplier for your needs.
A Gitoxin CoA (Certificate of Analysis) is a formal document that attests to Gitoxin's compliance with Gitoxin specifications and serves as a tool for batch-level quality control.
Gitoxin CoA mostly includes findings from lab analyses of a specific batch. For each Gitoxin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gitoxin may be tested according to a variety of international standards, such as European Pharmacopoeia (Gitoxin EP), Gitoxin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gitoxin USP).
LOOKING FOR A SUPPLIER?
